Pharmaceuticals in Singapore
SummaryPharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2016-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Singaporean pharmaceuticals market had total revenues of $1.3 billion in 2021, representing a compound annual growth rate (CAGR) of 5.9% between 2016 and 2021.
- Singaporean healthcare is one of the best in the world in terms of both efficiency and health outcome results and government healthcare expenditure has also been steadily on the rise, conditions which have been strongly conducive to market growth.
- The Singaporean government has invested aggressively in its biomedical industry over the last few years, encouraging the top companies to set up manufacturing units and R&D centers in the country.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Singapore
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Singapore
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Singapore pharmaceuticals market with five year forecasts by both value and volume
Reasons To Buy
- What was the size of the Singapore pharmaceuticals market by value in 2021?
- What will be the size of the Singapore pharmaceuticals market in 2026?
- What factors are affecting the strength of competition in the Singapore pharmaceuticals market?
- How has the market performed over the last five years?
- How large is Singapore’s pharmaceuticals market in relation to its regional counterparts?
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.